- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
WHO says another omicron subvariant, which may be more resistant to antibodies, spread to 26 countries in latest week
October 20, 2022
From MarketWatch
From Benzinga
Why Moderna Stock Dropped Today
October 19, 2022
From Motley Fool
Why Novavax Stock Couldn't Win on Wednesday
October 19, 2022
From Motley Fool
From Benzinga
Why BioNTech SE And Novavax Shares Are Diving
October 18, 2022
From Benzinga
CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15
October 17, 2022
From MarketWatch
From Motley Fool
Bulls And Bears Of The Week: Amazon, Tesla, Apple, Meta And Why An Analyst Is Turning Less Positive On 2 Legacy Automakers
October 15, 2022
From Benzinga
Why Novavax Stock Had an Ugly Friday
October 14, 2022
From Motley Fool
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
October 13, 2022
From MarketWatch
Pfizer/BioNTech's Updated Omicron Adapted COVID-19 Shot Increases Neutralizing Antibodies Above Pre-Booster Levels
October 13, 2022
From Benzinga
These 2 Stocks Gave Investors a Nice Surprise Wednesday
October 12, 2022
From Motley Fool
Why Pfizer Partner BioNTech SE Shares Are Trading Higher
October 12, 2022
From Benzinga
FDA Authorizes Pfizer/BioNtech's Updated COVID-19 Booster Shots For Kids 5-11 Years
October 12, 2022
From Benzinga
From Benzinga
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
October 10, 2022
From InvestorPlace
Pfizer's Executive Says European COVID-19 Vaccine Contract Negotiations Did Not Happen Over Text Message
October 10, 2022
From Benzinga
7 Blue-Chip Stocks That Are Too Cheap to Ignore
October 09, 2022
From InvestorPlace
Pfizer's Partner BioNTech Signs Research Pact With Australia
October 07, 2022
From Benzinga
From Motley Fool
1 in 5 of Americans don’t know about new omicron-targeting COVID boosters, survey finds
September 30, 2022
From MarketWatch
Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions
September 27, 2022
From MarketWatch
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
September 27, 2022
From Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
September 26, 2022
From MarketWatch
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
September 26, 2022
From Benzinga
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
September 26, 2022
From Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
September 26, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.